Sign in Subscribe
United States. Securities and Exchange Commission

Xoma Corp. Files SEC Form 4 for Pharmaceutical Preparations

Strategic Insights

— 1 min read

Xoma Corp. has made a new filing with the Securities and Exchange Commission (SEC) detailing a significant event in the pharmaceutical industry. According to the filing, Xoma Corp. has engaged in a notable transaction within the company, which is outlined in the document. This filing provides valuable insight into the company's financial activities and leadership structure.

Key Takeaways:

  • Xoma Corp. is a U.S. company operating in the pharmaceutical industry, as categorized by the SIC code 2834.
  • The company has filed a document with the SEC, indicating a change in ownership or leadership structure.
  • The filing, made on Form 4, is a required disclosure for directors, officers, or owners of over 10% of a class of equity securities.
  • The document provides information on the reporting person's relationship to the company and purchases or sales of equity securities.
  • The Xoma Corp. filing is a formal document submitted to the SEC, providing transparency into the company's financial activities.

Statistics:

  • The filing was made on March 23, 2015.
  • The document was submitted under the SEC file number 0000791908-15-000050.
  • As per SEC regulations, Xoma Corp. has filed the document within the specified timeframe.
  • The SIC code for Xoma Corp. is 2834, indicating the company's primary business as Pharmaceutical Preparations.

Sources:

  • Xoma Corp. (Form 4) filing on March 23, 2015.
  • United States Securities and Exchange Commission (SEC).
  • http://www.sec.gov/Archives/edgar/data/1210905/0000791908-15-000050-index.html

Read more